Category: Costs of Obesity

Five Anti-Obesity Medications Evaluated for Cost-Effectiveness

A primary consideration that this analysis could not investigate is the issue of long-term weight loss.

WeightControl.com Interview with:


Ainhoa Gomez-Lumbreras, MD, PhD
Post-Doctoral Fellow
Department of Pharmacotherapy
College of Pharmacy, University of Utah


Dan Malone, PhD
Professor
Department of Pharmacotherapy
College of Pharmacy, University of Utah
Salt Lake City, UT 84112

WeightControl.com:  What is the background for this study? 

Response: Obesity, defined as having a body mass index of 30 or more, is a multifactorial disease that has been associated with cardiovascular and respiratory diseases, diabetes, and others. By 2030 it is expected that half of the U.S. adult population will be obese. More pharmacologic products are being investigated for weight loss, including the new anti-diabetes medications liraglutide, semaglutide and tirzepatide.

Continue reading “Five Anti-Obesity Medications Evaluated for Cost-Effectiveness”

Increased Health Care Costs of Obesity Peak At Age 50

“Incremental lifetime costs of a patient with obesity or overweight (vs. normal weight) increased with the patient’s age, peaked at age 50, and decreased with older ages. However, weight reduction even in older adults still yielded incremental cost savings.”